6-aminoquinoline has been researched along with Cytomegalovirus Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cecchetti, V; Gatto, B; Gribaudo, G; Loregian, A; Massari, S; Mercorelli, B; Muratore, G; Pagni, S; Palù, G; Palumbo, M; Sinigalia, E; Tabarrini, O | 1 |
1 other study(ies) available for 6-aminoquinoline and Cytomegalovirus Infections
Article | Year |
---|---|
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein.
Topics: Aminoquinolines; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; Drug Synergism; Fibroblasts; Gene Expression Regulation, Viral; Humans; Immediate-Early Proteins; Trans-Activators; Transcription, Genetic; Virus Replication | 2010 |